Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002;22(4):339-42.
doi: 10.1007/BF02896781.

The mechanism of resistance of Pseudomonas aeruginosa to beta-lactam antibiotics and clinical significance

Affiliations

The mechanism of resistance of Pseudomonas aeruginosa to beta-lactam antibiotics and clinical significance

Jianxin Song et al. J Huazhong Univ Sci Technolog Med Sci. 2002.

Abstract

To study the resistant mechanism and clinical significance of pseudomonas aeruginosa to beta-lactam antibiotics, the outer membrane permeability rate of 30 P. aeruginosa strains to 5 beta-lactam antibiotics was measured and their production of beta-lactamase and the beta-lactamase genes they carried detected. Furthermore, the relationship between the permeability, beta-lactamase and the clinical effects of beta-lactam antibiotics was observed. By using 14C-penicillin and liquid-scintillant isotope assay, the affinity of penicillin binding proteins (PBPS) was measured and their roles in the resistant mechanism studied. It was revealed that the permeability rate was higher in sensitive strains than in resistant ones (P < 0.05). All strains harbored 1-4 beta-lactamase genes and produced beta-lactamase. Higher permeability rate and higher degree of stability to beta-lactamase indicated better clinical therapeutic effects. The affinity of PBPs changed little without regard to the permeability and beta-lactamase. These results suggested that the permeability of outer membrane and beta-lactamase, but not PBPs, played important roles in the resistant mechanism of P. aeruginosa to beta-lactam antibiotics and affected the clinical therapeutic effectiveness of some patients.

PubMed Disclaimer

Similar articles

References

    1. Emerg Infect Dis. 2000 Jan-Feb;6(1):84-5 - PubMed
    1. Antimicrob Agents Chemother. 1989 Nov;33(11):1831-6 - PubMed
    1. Antimicrob Agents Chemother. 1995 Feb;39(2):394-9 - PubMed
    1. J Antimicrob Chemother. 1998 Aug;42(2):272-3 - PubMed

Publication types

MeSH terms

LinkOut - more resources